Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Treatment With Candesartan vs Placebo in Asymptomatic Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)"

NCT05321875 is registered in ClinicalTrials.gov with Cristina Avendaño Solá as lead sponsor.

NCT NCT05321875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05321875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Treatment With Candesartan vs Placebo in Asymptomatic Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)"
Lead sponsor
Cristina Avendaño Solá
Phase
Phase 3
Overall status
Recruiting
Start date
June 2, 2022
Completion date
June 2, 2026
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy, dilated